National Research Center for Epidemiology and Microbiology named after N.F. Gamalei and the Ministry of Defense plan to complete all clinical trials of the COVID-19 vaccine by the end of July. On Wednesday, June 3, said the head of the 48th Central Scientific Research Institute (CRI) of the Ministry of Defense of Russia Sergey Borisevich in an interview.
The head of the institute noted that preclinical studies of the experimental sample of the vaccine have already been completed, they were carried out on two types of animals: hamsters and monkeys.
Borisevich also added that the studies showed and proved the safety of the drug and its protective effectiveness. In addition, according to the results of studies, scientists prepared scientific and technical documentation for obtaining permission to conduct clinical trials, including in humans.
Earlier, the Ministry of Defense reported that vaccine trials will be conducted at the 48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation. On June 3, the first group of military volunteers will go to a medical institution to examine and prepare for an experiment to test the vaccine against COVID-19.
Last week, Moscow Mayor Sergei Sobyanin announced the stabilization of the situation with coronavirus in the city. However, he allowed the restrictions to remain until the advent of the coronavirus vaccine.
At the same time, Russian President Vladimir Putin said that the country has passed the peak of incidence.
The spread of coronavirus SARS-CoV-2, which causes the disease COVID-19, began at the end of December last year. The focus of infection was the Chinese city of Wuhan. For several months, the disease has spread to more than 210 countries of the world. On March 11, WHO announced a coronavirus pandemic.